WAVE Life Sciences Ltd
NASDAQ:WVE

  • LAST PRICE
    13.6700
  • TODAY'S CHANGE (%)
    -1.3300 (-8.8667%)
  • Bid / Lots
    12.0000/ 2
  • Ask / Lots
    16.6100/ 2
  • Open / Previous Close
    15.1800 / 15.0000
  • Day Range
    13.6300
    15.2700
  • 52 Week Range
    3.5000
    16.7350
  • Volume
    1,432,900

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Biotechnology Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
WVE
WAVE Life Sciences Ltd
2.2B
-12.3x
---
MIRM
Mirum Pharmaceuticals Inc
2.2B
-21.0x
---
NRIX
Nurix Therapeutics Inc
1.9B
-7.9x
---
PTGX
Protagonist Therapeutics Inc
2.4B
15.4x
---
RXRX
Recursion Pharmaceuticals Inc
2.0B
-4.0x
---
ARVN
Arvinas Inc
1.7B
-4.7x
---
As of 2024-11-16

Company Information

Wave Life Sciences Ltd. is a biotechnology company. The Company is focused on unlocking the potential of RNA medicines (oligonucleotides), or those targeting ribonucleic acid (RNA), to transform human health. Its RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing and RNA interference (RNAi), providing Company with capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its diversified pipeline includes clinical programs in Duchenne muscular dystrophy, Alpha-1 antitrypsin deficiency and Huntington’s disease, as well as a preclinical program in obesity. These programs include WVE-N531, WVE-006 and WVE-003. It is also building a pipeline of novel A-to-I RNA editing oligonucleotides (AIMers).

Contact Information

Headquarters
7 Straits View #12-00, Marina One East Tower, Singapore 018936
Phone
---
Fax
---

Executives

Independent Chairman of the Board
Christian Henry
President, Chief Executive Officer, Director
Paul Bolno
Chief Financial Officer
Kyle Moran
Senior Vice President - Corporate Development, Head - Emerging Areas
Christopher Francis
Chief Technology Officer, Head - Platform Discovery Sciences
Chandra Vargeese

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$2.0B
Revenue (TTM)
$53.6M
Shares Outstanding
145.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
-1.25
EPS
$-1.11
Book Value
$0.40
P/E Ratio
-12.3x
Price/Sales (TTM)
37.1
Price/Cash Flow (TTM)
---
Operating Margin
-283.63%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.